KIF11 and pancreatic adenocarcinoma: According to previous studies, overexpression of KIF11 was shown in breast cancer [23], epithelial ovarian cancer [24], clear cell renal cell carcinoma [25], colorectal cancer [26], hepatocellular carcinoma [27], pancreatic adenocarcinoma [28], oral cancer [29], and lung cancer [30].